ALLERCLEAR dexchlorpheniramine maleate 2 mg tablets blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

dexchlorpheniramine maleate, Quantity: 2 mg

Disponibbli minn:

AFT Pharmaceuticals Pty Ltd

Għamla farmaċewtika:

Tablet, uncoated

Kompożizzjoni:

Excipient Ingredients: maize starch; magnesium stearate; pregelatinised maize starch; lactose

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

20s and 40s

Tip ta 'preskrizzjoni:

(S3) Pharmacist Only Medicine

Indikazzjonijiet terapewtiċi:

ALLERCLEAR is indicated for symptomatic treatment of perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild uncomplicated allergic skin manifestations of urticaria and,angioedema. ALLERCLEAR may relieve itching due to skin conditions such as allergic eczema, pruritus ani, pruritus vulvae, atopic dermatitis, contact dermatitis, insect bites, dermographism and medicine reactions, including serum sickness.

Sommarju tal-prodott:

Visual Identification: White to off white, round, flat faced beveled edge tablets, score on one side and plain on other side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2020-11-12